The COVID-19 crisis has increased the adoption of artificial intelligence in clinical oncology trials. Here’s what it means for patient recruitment, retention and outcomes.
Source : https://www.healthcareitnews.com/news/spurred-pandemic-ai-driving-decentralized-clinical-trials
Date : April 8, 2021 at 08:24PM
Tag(s) : #eSANTE ENG
